Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating an artificial intelligence-assisted personalized heat-risk alert system designed to reduce heat-related illness symptoms among adults with chronic conditions such as hypertension, type 2 diabetes, chronic kidney disease, cardiovascular disease, or obesity. The study compares this AI-based alert system with a generic heat-health advisory from the Pakistan Meteorological Department, aiming to improve personalized risk awareness and protective behaviors during extreme heat events. Participants will be randomly assigned to one of two groups. The intervention group will receive personalized heat-risk alerts via a mobile app on days when the forecasted maximum temperature is 36C or higher. This system uses a locked AI model that combines individual clinical data with weather forecasts to classify risk levels and deliver tailored messages. The control group will get a generic heat advisory through the same app without personalized risk classification. The study lasts six weeks, during which participants are monitored and supported. Throughout the trial, participants will engage with the mobile app and be assessed at baseline and after six weeks for heat-related illness symptoms using the Heat-Related Illness Symptom Score. Additional measures include heat-protective behaviors, knowledge and attitudes about heat health, emergency visits, hospital admissions, and app engagement. The researchers will monitor participants health and behavior to evaluate the systems impact on reducing heat-related illness burden.
Actively Recruiting
Researchers are evaluating whether adding platelet-rich plasma PRP to fractional carbon dioxide CO2 laser treatment improves the appearance of moderate-to-severe acne scars compared with laser treatment alone. This randomized controlled trial will involve 70 adults aged 18 to 40 years with moderate-to-severe facial acne scars. The study aims to see if PRP enhances the effectiveness and safety of laser therapy while improving patient satisfaction. Participants will be randomly assigned to one of two groups. One group will receive fractional CO2 laser therapy combined with topical PRP applied immediately after treatment. The other group will receive fractional CO2 laser therapy alone, with a placebo procedure to maintain blinding. Both groups will undergo three treatment sessions spaced four weeks apart. PRP is prepared using a standardized double-spin centrifugation method from the participants own blood. During the study, participants will be assessed at baseline and each visit for acne scar severity using the Goodman and Baron Quantitative Acne Scar Scale, along with redness, swelling, pain, and patient satisfaction. Standardized photographs will support evaluations. Data will be analyzed with statistical tests, keeping patient groups blinded. Safety and treatment effects will be closely monitored across the 12-week follow-up period.